Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Venous Thromboembolism × Tacrolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 18 Myelodysplastic Syndromes 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Leukemia 12 Multiple Myeloma 10 Lymphoma, Non-Hodgkin 9 Lymphoma 9 Hodgkin Disease 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Primary Myelofibrosis 6 Myeloproliferative Disorders 6 Leukemia, Myeloid, Chronic-Phase 6 Hematologic Neoplasms 6 Neoplasms, Plasma Cell 5 Leukemia, Myelomonocytic, Chronic 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Congenital Abnormalities 5 Blast Crisis 5 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Burkitt Lymphoma 4 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

apixaban 1 Tacrolimus 1 Gemcitabine 1 Fondaparinux 1 Drug Therapy 1 Cyclosporine 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083782 2017-10-11

ACT

Thomas Jefferson University

Phase 1 Completed

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡